Gutiérrez F, Sánchez-Cantalejo E, Garcia-Olivares E, Garrido F, Osorio C
Rev Esp Fisiol. 1980 Sep;36(3):243-7.
The capacity of 14 cancer patients lymphoid cells to destroy antibody-coated target cells (antibody-dependent cell cytotoxicity ADCC), and to form rosettes with immunoglobulin-coated erythrocytes (EA) was compared. The lymphocyte functions were investigated immediately prior to chemo-immunotherapy. Our observations show a correlation between the percentage of EA-rosette forming cells and ADCC activity of cancer patients and controls. However, the regressive lines were different in both groups. Interestingly, cancer patients with a lower. EA rosette forming cells than controls, showed higher cytotoxic activity.
比较了14名癌症患者淋巴细胞破坏抗体包被靶细胞(抗体依赖性细胞毒性,ADCC)以及与免疫球蛋白包被红细胞(EA)形成玫瑰花结的能力。在化学免疫治疗之前立即研究淋巴细胞功能。我们的观察结果表明,癌症患者和对照组中EA玫瑰花结形成细胞的百分比与ADCC活性之间存在相关性。然而,两组的回归线不同。有趣的是,EA玫瑰花结形成细胞低于对照组的癌症患者表现出更高的细胞毒性活性。